Thank You for Signing Up!

We’re thrilled to welcome you as an email subscriber. Your support helps advance scholarly research and ensures access to cutting-edge psychiatry articles and insights.

Personalize Your Experience

Help us customize your content and recommendations by verifying your professional credentials with your National Provider Identifier (NPI).

Note: You’ll need to log in or create an account to save your NPI information.

Do you have an NPI number?

Choose your interests

Select topics that interest you to receive personalized recommendations and content.

Our Recently Published Articles

PCC
Zolpidem for Severe Insomnia Associated With Delirium in Critical Illness
Case Report

June 11, 2026

A critically ill patient with sepsis and persistent delirium with treatment-refractory insomnia experienced rapid improvement in sleep continuity, delirium severity, and bedside cognitive performance with zolpidem.
, ,
JCP
Placebo Effects in Alcohol, Cocaine, and Methamphetamine Use Disorder
Meta-Analysis

June 10, 2026

Placebo treatment led to reductions in craving scores across all three disorders, although statistical significance was achieved only in alcohol use disorder.
, , , et al
JCP
Hallucinogen–Psychosis Associations Are Confounded by Baseline Psychiatric History
Original Research ▶ Video

June 10, 2026

Apparent associations between hallucinogen use and psychosis appear largely attributable to baseline psychiatric comorbidities rather than direct causal effects.
, , , et al
PCC
Prevalence of Anxiety in an Underserved Population
Original Research

June 9, 2026

Generalized anxiety disorder is highly prevalent in underserved Venezuelan populations, particularly among women, highlighting the need for routine screening in primary care settings
, , , et al
JCP
County-Level Variation in Substance Use Disorder Service Utilization by Insurance Payers and Self-Pay
Original Research ▶ Video

June 8, 2026

Across all examined payers, Medicaid funded a disproportionate share—over 50%—of SUD service expenditures.
, , , et al
PCC
Catatonia Induced by D2R Antagonist Antiemetics
Case Report

June 4, 2026

The authors describe a rare case of catatonia correlated with abuse of D2R antagonist antiemetic medications in a 52-year-old man with multiple sclerosis.
, ,
JCP
SSRI Discontinuation and AUD Relapse
Case Report

August 26, 2024

A man with AUD achieves sobriety on treatment with an SSRI and naltrexone, but then stops taking the SSRI to participate in a psilocybin “ceremony.” What factors contributed to…
, , , et al
JCP
Olanzapine and Mirtazapine for Cancer-Related Anorexia
Clinical and Practical Psychopharmacology

August 21, 2024

Dr Andrade discusses two RCTs that investigated the utility of olanzapine and mirtazapine in addressing appetite loss in cancer patients.
JCP
Functional Unblinding in Pivotal Studies and the Future of Psychedelic Medicine
Commentary

August 21, 2024

Dr Rosenbaum comments on the challenge of evaluating trials of treatments whose effects are unmistakable, and how this dilemma may be addressed.

Insightful. Evidence-based. Human-centered.

Listen to the JCP Podcast Now
Figure: Digital illustration shows a human head with neural connections and podcast title over a dark blue patterned background.

Subscribe to read
more articles

Subscribe